Stitch RNA: New Method for Duchenne Gene Therapies
The Stitch RNA (StitchR) method could accelerate the development of new drugs that could significantly treat Duchenne Muscular Dystrophy.
Loss of the DNA code that...
AlltRNA’s Engineered tRNA Technology Could Offer Hope for Nonsense Mutations
Regardless of the impacted protein, Alltrna is creating designed tRNA medications that can read through premature termination codons and resume production of the impacted...
Nanoparticles Used as Vehicle to Deliver MicroRNAs to Cells and Treat Duchenne Muscular Dystrophy
In a collaboration between the IMDEA Nanociencia Institute (Madrid), Università Cattolica del Sacro Cuore (Rome), and the University of Bordeaux, researchers have made an...
ENCell Confirms Safety of DMD Stem Cell Therapy EN001 in Phase 1 Clinical Trial in Korea
The bio corporation ENCell reported on February 13 that it confirmed the safety and tolerability of its developing next-generation mesenchymal stem cell therapy EN001...
Satellos Announces Completed Enrollment of Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers
Satellos Bioscience, a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced it...